The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

Mark Haas(Cedars-Sinai Medical Center), Michael Mengel(University of Alberta), Peter Nickerson(Shared Services Canada), Maarten Naesens(KU Leuven), Nada Alachkar(Johns Hopkins University), Daniel Serón(Vall d'Hebron Hospital Universitari), Dorry L. Segev(New York University), Ian W. Gibson(University of Manitoba), Denis Glotz(Metabolism and Renal Physiology), Yassine Bouatou(Délégation Paris 5), Kim Solez(University of Alberta), Harsharan K. Singh(University of North Carolina at Chapel Hill), Candice Roufosse(Centre for Inflammation Research), Jan U. Becker(University Hospital Cologne), Serena M. Bagnasco(Johns Hopkins University), Roslyn B. Mannon(University of Nebraska Medical Center), Alexandre Loupy(Hôpital Necker-Enfants Malades), Mark D. Stegall(Mayo Clinic in Arizona), Brian J. Nankivell(Westmead Hospital), Philip F. Halloran(University of Alberta), Enver Akalin(Brigham and Women's Hospital), Parmjeet Randhawa(University of Pittsburgh), Lynn D. Cornell(University of Calgary), Carmen Lefaucheur(Inserm), J.P. Duong Van Huyen(Hôpital Necker-Enfants Malades), Edward S. Kraus(Johns Hopkins University), Volker Nickeleit(University of North Carolina at Chapel Hill), Lorraine C. Racusen(Johns Hopkins University), Robert B. Colvin(Harvard University)

American Journal of Transplantation

December 16, 2017

Cited by 1,032

|Kidney International|1999|3.1k

|American Journal of Transplantation|2008|1.9k

|Journal of Clinical Investigation|1981|1.7k

|American Journal of Transplantation|2011|1.6k

|Clinical Journal of the American Society of Nephrology|2009|1.5k

Related Papers